These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24795010)

  • 21. [Cancer therapy by PARP inhibitors].
    Seimiya H
    Nihon Rinsho; 2015 Aug; 73(8):1330-5. PubMed ID: 26281686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
    Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
    Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer.
    Vanderstichele A; Busschaert P; Olbrecht S; Lambrechts D; Vergote I
    Eur J Cancer; 2017 Nov; 86():5-14. PubMed ID: 28950147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting homologous recombination repair defects in cancer.
    Evers B; Helleday T; Jonkers J
    Trends Pharmacol Sci; 2010 Aug; 31(8):372-80. PubMed ID: 20598756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells.
    Du LQ; Du XQ; Bai JQ; Wang Y; Yang QS; Wang XC; Zhao P; Wang H; Liu Q; Fan FY
    J Cancer Res Clin Oncol; 2012 May; 138(5):811-8. PubMed ID: 22274865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA Double Strand Breaks Repair Inhibitors: Relevance as Potential New Anticancer Therapeutics.
    Kopa P; Macieja A; Galita G; Witczak ZJ; Poplawski T
    Curr Med Chem; 2019; 26(8):1483-1493. PubMed ID: 29446719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways.
    Ito SS; Nakagawa Y; Matsubayashi M; Sakaguchi YM; Kobashigawa S; Matsui TK; Nanaura H; Nakanishi M; Kitayoshi F; Kikuchi S; Kajihara A; Tamaki S; Sugie K; Kashino G; Takahashi A; Hasegawa M; Mori E; Kirita T
    J Biol Chem; 2020 Sep; 295(37):12946-12961. PubMed ID: 32675286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application and reflection of genomic scar assays in evaluating the efficacy of platinum salts and PARP inhibitors in cancer therapy.
    Gou R; Dong H; Lin B
    Life Sci; 2020 Nov; 261():118434. PubMed ID: 32941897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment.
    Balboni A; Govoni M; Rossi V; Roberti M; Cavalli A; Di Stefano G; Manerba M
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129760. PubMed ID: 33035602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks.
    Medová M; Aebersold DM; Zimmer Y
    Int J Cancer; 2012 Feb; 130(3):728-34. PubMed ID: 21400509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.
    Rimar KJ; Tran PT; Matulewicz RS; Hussain M; Meeks JJ
    Cancer; 2017 Jun; 123(11):1912-1924. PubMed ID: 28323334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy.
    Mio C; Gerratana L; Bolis M; Caponnetto F; Zanello A; Barbina M; Di Loreto C; Garattini E; Damante G; Puglisi F
    Int J Cancer; 2019 Feb; 144(4):755-766. PubMed ID: 30259975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors.
    Liu FW; Tewari KS
    Curr Treat Options Oncol; 2016 Mar; 17(3):12. PubMed ID: 26931795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased DNA repair activity in bone marrow due to low expression of DNA damage repair proteins.
    So EY; Ouchi T
    Cancer Biol Ther; 2014 Jul; 15(7):906-10. PubMed ID: 24755532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploiting the nucleotide substrate specificity of repair DNA polymerases to develop novel anticancer agents.
    Crespan E; Garbelli A; Amoroso A; Maga G
    Molecules; 2011 Sep; 16(9):7994-8019. PubMed ID: 21926946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.
    Zhang L; Peng Y; Uray IP; Shen J; Wang L; Peng X; Brown PH; Tu W; Peng G
    DNA Repair (Amst); 2017 Dec; 60():89-101. PubMed ID: 29112893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate Cancer Cells to PARP-Inhibitors.
    Criscuolo D; Morra F; Giannella R; Cerrato A; Celetti A
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms.
    Kuo CY; Chou WC; Wu CC; Wong TS; Kakadiya R; Lee TC; Su TL; Wang HC
    Oncotarget; 2015 Sep; 6(28):25770-83. PubMed ID: 26208482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrations in DNA repair pathways in cancer and therapeutic significances.
    Motegi A; Masutani M; Yoshioka KI; Bessho T
    Semin Cancer Biol; 2019 Oct; 58():29-46. PubMed ID: 30922960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
    Stover EH; Konstantinopoulos PA; Matulonis UA; Swisher EM
    Clin Cancer Res; 2016 Dec; 22(23):5651-5660. PubMed ID: 27678458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.